Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/23/2002EP1250151A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
10/23/2002EP1250141A1 Prevention and treatment of endotoxemia and related complications associated with surgery
10/23/2002EP1250140A2 Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound
10/23/2002EP1250139A1 Product for treating gynecomastia
10/23/2002EP1250138A1 Fulvestrant formulation
10/23/2002EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002EP1250136A1 Methods for the treatment of substance abuse
10/23/2002EP1250135A1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/23/2002EP1250134A1 Compositions for the prevention of diaper dermatitis
10/23/2002EP1250133A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/23/2002EP1250132A1 Ibuprofen containing active agent preparation
10/23/2002EP1250131A2 Modulation of the blood-brain barrier transporter for leptin
10/23/2002EP1250130A1 Propofol formulation with enhanced microbial inhibition
10/23/2002EP1250129A2 METHODS TO TREAT $g(a)-1-ANTITRYPSIN DEFICIENCY
10/23/2002EP1250128A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
10/23/2002EP1250127A1 A method of administering a medicinal aerosol formulation
10/23/2002EP1250125A2 Pharmaceutical compositions comprising terbinafine
10/23/2002EP1250124A2 Slimming cosmetic composition comprising as active agent a plant extract containing a plant natriuretic peptide (pnp)
10/23/2002EP1250119A2 Reduction of hair growth
10/23/2002EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002EP1250094A1 Tunable indocyanine dyes for biomedical applications
10/23/2002EP1250093A1 Novel indocyanine dyes
10/23/2002EP1250092A1 Novel dyes
10/23/2002EP1250046A1 Improved topical drug delivery composition and method
10/23/2002EP1250045A2 Particulate blends and compacted products formed therefrom, and the preparation thereof
10/23/2002EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002EP1161427B1 Improved process for asymmetric hydrogenation
10/23/2002EP1159966B1 Composition for the treatment of psoriasis
10/23/2002EP1140191B1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
10/23/2002EP1091959B1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
10/23/2002EP1086095B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
10/23/2002EP1084325B1 Arrangement for the removal of cuttings and gas arising from drilling operations
10/23/2002EP1073664B1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/23/2002EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002EP1066297B1 Phosphinic acid derivatives
10/23/2002EP1009380B1 Method for preparing pharmaceutical formulations
10/23/2002EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same
10/23/2002EP1000063B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
10/23/2002EP0994727B1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
10/23/2002EP0979229B1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors
10/23/2002EP0925303B1 Phosphinic acid amides as matrix metalloprotease inhibitors
10/23/2002EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002EP0914118B1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/23/2002EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002EP0883681B1 Conjugated linoleic acids for attenuating the allergic response
10/23/2002EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002EP0843547B1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
10/23/2002EP0785191B1 Fused indan derivatives and salts thereof
10/23/2002EP0783499B1 Benzofuran derivatives as tachykinin antagonists
10/23/2002EP0772446B1 Anti-adhesion agent
10/23/2002EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002EP0754037A4 Methods of administering n-substituted benzamides or phenothiazines
10/23/2002EP0719141B1 Novel use of dexmedetomidine
10/23/2002EP0717991B1 Neurotropic agent and process for producing it
10/23/2002EP0702556B1 (phospho)lipids for combatting hepatitis b virus infection
10/23/2002EP0674630B1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/23/2002EP0626845B1 Improved amino acid solutions for treatment of peritoneal dialysis patients
10/23/2002CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002CN1376161A Novel bicyclonucleoside analogues
10/23/2002CN1376160A Novel macrolide antibiotics
10/23/2002CN1376156A Benzodiazepin derivatives, the production and use thereof
10/23/2002CN1376155A Thiourea and isothiourea derivatives for inhibiting RAS-transformed cell growth
10/23/2002CN1376154A Piperidine derivatives as serotonine reuptake inhibitors
10/23/2002CN1376153A Amide compounds
10/23/2002CN1376148A Rate-controlled particles
10/23/2002CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002CN1376072A Metabolic intervention with GLP-1 or its biologically active analygues to improve the function of the ischemic and reperfused brain
10/23/2002CN1376070A Method for the therapeutic management of extrauterine prolifieration of endometrical tissue, chronic pelvic pain and fallopian tube obstruction
10/23/2002CN1376069A Methods and compositions for reducing sympathomimetic-induced side effects
10/23/2002CN1376068A Echinacea supplement and method of manufacture
10/23/2002CN1376066A Use of H1 antagonist and a safe steroid to treat eye conditions
10/23/2002CN1376065A Compositions having improved stability
10/23/2002CN1376064A Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties
10/23/2002CN1376063A Cyclic amine CCR3 antagonisis
10/23/2002CN1376062A Use of amino acids for making medicine for treating to insulin-resistance
10/23/2002CN1376061A Treatment of hiatial hernia
10/23/2002CN1376058A Oral controlled release formulations
10/23/2002CN1376057A Anti-virus composition
10/23/2002CN1376055A Aerosol ointment compositions and method of manufacture
10/23/2002CN1376054A Topcial suspension formulations containing ciprofloxacin and dexa methasone
10/23/2002CN1376050A Skin care composition
10/23/2002CN1376043A Drug delivery of phase changing formulation
10/23/2002CN1376036A Metal-containing compositions, preparations and uses
10/23/2002CN1375494A Iso-indolo-indolone compound, their preparation methods and drug compositions comprising the same
10/23/2002CN1375490A Novel indeno indolone compound, its preparation method and drug composition comprising the same
10/23/2002CN1375332A Composition and method for making Akt cancer gene inactivate and activating P38 precell fade-out gene
10/23/2002CN1375331A Antiphlogistic capsule capable of keeping the adverse energy downwards
10/23/2002CN1375313A Recipe and prepn. process of medicine for treating burns and scalds
10/23/2002CN1375293A Mixed vermifuge injection containing iodo-ether salicylamine
10/23/2002CN1375292A Mixed snuff prepn. for reducing side effect of Apomorphinum
10/23/2002CN1375291A Veterinary mixed injection containing levamisole or its salts
10/23/2002CN1375290A Method for releasing L-asorbic substance to dermis layer of skin and composition thereof
10/23/2002CN1375289A Ampelosis general flavone composition with liver protecting function
10/23/2002CN1375288A Composite medicine for treating cerebrovascular diseases
10/23/2002CN1375287A Veterinary mixed suspension injection containing chlorocyaniosaliamine or its sodium salt
10/23/2002CN1375286A Sesquiterpene component with nerve calming soporific function and its medicinal use
10/23/2002CN1375285A Zinc glycinate capsule
10/23/2002CN1093133C 10,13,15-trioxyheterotricyclo [9,2,1,1,9,6]-pentadecanone derivatives, its preparing method and medicine containing it
10/23/2002CN1093130C Substituted pyrido 6,6-bicyclic derivatives
1 ... 5673 5674 5675 5676 5677 5678 5679 5680 5681 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 ... 7860